9,10-Di(2-naphthyl)anthracene

Suppliers

Names

[ Name ]:
9,10-Di(2-naphthyl)anthracene

[Synonym ]:
9,10-Di(naphthalen-2-yl)anthracen
9,10-Di(naphthalen-2-yl)anthracene
9,10-dinaphthalen-2-ylanthracene
Anthracene, 9,10-di-2-naphthalenyl-
9,10-Di-2-naphthalenyl-anthracene,ADN
MFCD00028944
9,10-Di(2-naphthyl)anthracene
9,10-Di(naphth-2-yl)anthracene

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
595.4±45.0 °C at 760 mmHg

[ Melting Point ]:
382-384ºC

[ Molecular Formula ]:
C₃₄H₂₂

[ Molecular Weight ]:
430.539

[ Flash Point ]:
314.8±22.8 °C

[ Exact Mass ]:
430.172150

[ LogP ]:
10.66

[ Vapour Pressure ]:
0.0±0.8 mmHg at 25°C

[ Index of Refraction ]:
1.761

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302

[ Hazard Codes ]:
Xn

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
36/37/38

[ RIDADR ]:
NONH for all modes of transport

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

2-Bromonaphthalene
9,10-Dibromo anthracene
9,10-di-[2]naphthyl-9,10-dihydro-anthracene-9,10-diol
Anthraquinone

DownStream

Articles

Biosynthesis of cell envelope-associated phenolic glycolipids in Mycobacterium marinum.

J. Bacteriol. 197(6) , 1040-50, (2015)

Phenolic glycolipids (PGLs) are polyketide synthase-derived glycolipids unique to pathogenic mycobacteria. PGLs are found in several clinically relevant species, including various Mycobacterium tuberc...

Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting.

Int. J. Pharm. 486 , 287-96, (2015)

Delivering chemotherapeutics by nanoparticles into tumor is impeded majorly by two factors: nonspecific targeting and inefficient penetration. Targeted delivery of anti-cancer agents solely to tumor c...

Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target.

Tuberculosis (Edinb.) 95 , 589-98, (2015)

DNA topoisomerases perform the essential function of maintaining DNA topology in prokaryotes. DNA gyrase, an essential enzyme that introduces negative supercoils, is a clinically validated target. How...

9,10-Di(2-naphthyl)anthracene
2-Bromo-9,10-di(2-naphthyl)anthracene
2-Methyl-9,10-di(2-naphthyl)anthracene
2,6-Dibromo-9,10-di(2-naphthyl)anthracene
9,10-di(2-naphthyl)anthracene-2-boronic acid
2-(2-Methyl-2-propanyl)-9,10-di(2-naphthyl)anthracene
7-((1-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl)amino)-3-(2-fluorophenyl)pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione
4-[(2-Chlorophenyl)methyl]-1-[3-[4-(2-fluorophenyl)piperazin-1-yl]-3-oxopropyl]-3,3a,5a,6,7,8,9,9a-octahydro-[1,2,4]triazolo[4,3-a]quinazolin-5-one
3-[4-[(2-chlorophenyl)methyl]-5-oxo-3,3a,5a,6,7,8,9,9a-octahydro-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]-N-(2-phenylpropyl)propanamide
3'-Bromo-3-methanesulfonyl-biphenyl
N-[2-(1H-indol-3-yl)ethyl]-3-[5-oxo-4-(2-phenylethyl)-3,3a,5a,6,7,8,9,9a-octahydro-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]propanamide
Ethyl 4-(6-cyclopentyl-5,7-dioxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-2-yl)piperazine-1-carboxylate
N-(4-methoxyphenyl)-3-[5-oxo-4-(2-phenylethyl)-3,3a,5a,6,7,8,9,9a-octahydro-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]propanamide
N-(3-methoxyphenyl)-3-[5-oxo-4-(2-phenylethyl)-3,3a,5a,6,7,8,9,9a-octahydro-[1,2,4]triazolo[4,3-a]quinazolin-1-yl]propanamide
1-[3-oxo-3-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)propyl]-4-(2-phenylethyl)-3,3a,5a,6,7,8,9,9a-octahydro-[1,2,4]triazolo[4,3-a]quinazolin-5-one
7-[(2-cyclohex-1-en-1-ylethyl)amino]-3-cyclopentylpyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.